id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0003-0004,FDA,FDA-2002-P-0003,FDA/OC to Johnson & Johnson,Other,PAV-Petition Approval,2003-04-17T04:00:00Z,2003,4,,,2008-04-12T01:25:45Z,,0,0,09000064804870c2
FDA-2002-P-0003-0003,FDA,FDA-2002-P-0003,FDA/DDM to Johnson & Johnson,Other,ACK-Acknowledgement Letter,2002-07-02T04:00:00Z,2002,7,,,2008-04-12T01:25:45Z,,0,0,09000064804870bf
FDA-2002-P-0003-0002,FDA,FDA-2002-P-0003,"FDA/CDER to Caraco Pharms Labs, Ltd.",Other,PAV-Petition Approval,2002-06-12T04:00:00Z,2002,6,,,2008-04-12T01:25:45Z,,0,0,09000064804870b7
FDA-2002-P-0003-0001,FDA,FDA-2002-P-0003,FDA/DDM to Winston & Strawn,Other,ACK-Acknowledgement Letter,2002-05-31T04:00:00Z,2002,5,,,2008-04-12T01:25:45Z,,0,0,090000648048707d